Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study

Autor: Fisher, Benjamin A, Szanto, Antonia, Ng, Wan-Fai, Bombardieri, Michele, Posch, Maximilian G, Papas, Athena S, Farag, Arwa M, Daikeler, Thomas, Bannert, Bettina, Kyburz, Diego, Kivitz, Alan J, Carsons, Steven E, Isenberg, David A, Barone, Francesca, Bowman, Simon J, Espié, Pascal, Floch, David, Dupuy, Cyrielle, Ren, Xiaohui *, Faerber, Petra M, Wright, Andrew M, Hockey, Hans-Ulrich, Rotte, Michael, Milojevic, Julie, Avrameas, Alexandre, Valentin, Marie-Anne, Rush, James S, Gergely, Peter *
Zdroj: In The Lancet Rheumatology March 2020 2(3):e142-e152
Databáze: ScienceDirect